RNAi
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
48
NCT05902520
Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors
Phase: Phase 1
Role: Collaborator
Start: Jun 19, 2023
Completion: May 19, 2026
NCT06014086
Intratumoral PH-762 for Cutaneous Carcinoma
Role: Lead Sponsor
Start: Nov 7, 2023
Completion: Apr 30, 2026
Loading map...